Culwell Kelly 4
4 · Evofem Biosciences, Inc. · Filed Feb 3, 2021
Insider Transaction Report
Form 4
Culwell Kelly
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2021-02-03+150,000→ 150,000 totalExercise: $3.25Exp: 2031-02-03→ Common Stock (150,000 underlying) - Award
Common Stock
2021-02-03+200,000→ 315,451 total
Footnotes (2)
- [F1]The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2021.
- [F2]The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 3, 2021.